Begin with the end in mind: designing synthetic antibiotics with a universal mechanism of action
The rising threat of antimicrobial resistance (AMR) is prompting many researchers to investigate potential new antibiotics. Preventing the spread of dangerous bacteria, especially in a hospital environment, could save the lives of many patients who die from conditions such as sepsis.
Drug Target Review’s Victoria Rees spoke to James Graham, Executive Director of Recce Pharmaceuticals, to find out how researchers are attempting to combat harmful bacteria with a novel range of synthetic antibiotics.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.